{"id":"ost","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Esophageal irritation"},{"rate":"5-10%","effect":"Dental problems"},{"rate":"5-10%","effect":"Musculoskeletal pain"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108162","moleculeType":"Antibody"},"_dailymed":{"setId":"e4dd8b84-b27e-4899-b3ae-d6d20d367669","title":"OSTIFEN (CARPROFEN STERILE) INJECTION, SOLUTION [MWI/VETONE]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"OST works by inhibiting the activity of osteoclasts, which are cells responsible for bone resorption. This leads to an increase in bone density and a decrease in the risk of fractures. OST is used to treat osteoporosis and other bone-related disorders.","oneSentence":"OST is an osteoclast inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:59:07.601Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of osteoporosis in postmenopausal women and men"},{"name":"Treatment of glucocorticoid-induced osteoporosis"}]},"trialDetails":[{"nctId":"NCT03175874","phase":"NA","title":"Autophagy and Pathological Aging","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2017-12-20","conditions":"Osteoporosis","enrollment":82},{"nctId":"NCT07402772","phase":"","title":"Female Osteoporosis","status":"NOT_YET_RECRUITING","sponsor":"Kayseri City Hospital","startDate":"2026-02-04","conditions":"Female Osteoporosis","enrollment":1500},{"nctId":"NCT07281092","phase":"NA","title":"Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)","status":"RECRUITING","sponsor":"Seattle Children's Hospital","startDate":"2025-10-01","conditions":"ADHD, ADHD - Attention Deficit Disorder With Hyperactivity","enrollment":36},{"nctId":"NCT07089745","phase":"NA","title":"Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-09-18","conditions":"ADHD, ADHD - Attention Deficit Disorder With Hyperactivity","enrollment":30},{"nctId":"NCT07195409","phase":"NA","title":"Data Coaching Process to Address Staff Physical Activity Promoting Behavior and Child Physical Activity","status":"RECRUITING","sponsor":"Kansas State University","startDate":"2025-09-10","conditions":"Physical Activity","enrollment":80},{"nctId":"NCT03155906","phase":"NA","title":"Integrated Treatment of Hepatitis C Virus Infection","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2017-05-18","conditions":"Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy","enrollment":298},{"nctId":"NCT07117656","phase":"NA","title":"Project Vuselela Feasibility","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-07-13","conditions":"HIV, Drug Users","enrollment":80},{"nctId":"NCT04961515","phase":"PHASE2","title":"Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-07-01","conditions":"Primary Central Nervous System Hodgkin Lymphoma","enrollment":19},{"nctId":"NCT05779566","phase":"","title":"Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2023-01-09","conditions":"Breast Cancer, Osteopenia","enrollment":82},{"nctId":"NCT03443323","phase":"NA","title":"Organizational Skills Training - Tier 2 (OST-T2)","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2017-11-08","conditions":"Executive Function, Behavioral Research, Schools","enrollment":186},{"nctId":"NCT06287606","phase":"PHASE3","title":"A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Taejoon Pharmaceutical Co., Ltd.","startDate":"2023-08-29","conditions":"Bowel Preparation","enrollment":161},{"nctId":"NCT06651996","phase":"NA","title":"Adherence and Feasibility of Remote Rehabilitation for Chronic Patellofemoral Joint Pain: a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2023-09-10","conditions":"Patellofemoral Pain","enrollment":63},{"nctId":"NCT04108273","phase":"NA","title":"Brain Plasticity Underlying Acquisition of New Organizational Skills in Children","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2019-10-01","conditions":"ADHD, Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders","enrollment":59},{"nctId":"NCT04563390","phase":"NA","title":"Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia.","status":"RECRUITING","sponsor":"Universitat Jaume I","startDate":"2020-11-01","conditions":"Specific Phobia","enrollment":96},{"nctId":"NCT04563403","phase":"NA","title":"Improving the Efficacy of Exposure Therapy for the Treatment of Cockroach Phobia","status":"RECRUITING","sponsor":"Universitat Jaume I","startDate":"2020-11-30","conditions":"Specific Phobia, Animal","enrollment":80},{"nctId":"NCT03685045","phase":"NA","title":"ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings","status":"RECRUITING","sponsor":"Kirby Institute","startDate":"2018-05-28","conditions":"Hepatitis C","enrollment":6000},{"nctId":"NCT05386251","phase":"PHASE2, PHASE3","title":"Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges","status":"UNKNOWN","sponsor":"Seattle Children's Hospital","startDate":"2022-05-18","conditions":"ADHD","enrollment":120},{"nctId":"NCT05249335","phase":"PHASE4","title":"Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly","status":"UNKNOWN","sponsor":"Pharmbio Korea Co., Ltd.","startDate":"2022-02","conditions":"Colonic Disease, Intestinal Disease","enrollment":256},{"nctId":"NCT03935906","phase":"NA","title":"Reaching mEthadone Users Attending Community pHarmacies With HCV","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2019-10-08","conditions":"Hepatitis C","enrollment":210},{"nctId":"NCT04251572","phase":"NA","title":"HCV Reinfection After DAA Therapy in PWID in Belgium","status":"UNKNOWN","sponsor":"Hasselt University","startDate":"2019-07-01","conditions":"Hepatitis C Virus Infection, Response to Therapy of, Drug Use","enrollment":100},{"nctId":"NCT04017429","phase":"NA","title":"Osteoplasty in Conjunction With Surgical Treatment of Mandibular Grade III Furcation Defects (FURC-III-OST)","status":"WITHDRAWN","sponsor":"University of Oslo","startDate":"2019-10-15","conditions":"Furcation Defects, Periodontal Diseases","enrollment":""},{"nctId":"NCT02533310","phase":"NA","title":"Virtual Reality Immersive Method for Spider (Phobia) Exposure Therapy (VIMSE)","status":"COMPLETED","sponsor":"Stockholm University","startDate":"2015-08-01","conditions":"Phobia, Specific","enrollment":100},{"nctId":"NCT02444403","phase":"NA","title":"Police Training to Reduce Occupational Needlesticks and HIV Among Substance Users","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-06","conditions":"Occupational Needlestick Injuries","enrollment":500},{"nctId":"NCT02663986","phase":"NA","title":"Organizational Skill Training (OST) in Schools","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2015-02-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":35},{"nctId":"NCT03885414","phase":"NA","title":"Virtual Reality Exposure Therapy for Public Speaking Anxiety","status":"COMPLETED","sponsor":"Stockholm University","startDate":"2019-01-14","conditions":"Public Speaking, Social Anxiety, Social Anxiety Disorder, Performance Only","enrollment":23},{"nctId":"NCT01722435","phase":"","title":"Completion of OST - a Prospective Study","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2011-07","conditions":"Opioid Dependence","enrollment":78},{"nctId":"NCT03148782","phase":"NA","title":"Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2017-09-08","conditions":"ADHD, Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders","enrollment":42},{"nctId":"NCT02706223","phase":"NA","title":"Testing and Treating Hepatitis C in Community Pharmacies","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2016-12","conditions":"Hepatitis C","enrollment":356},{"nctId":"NCT01847729","phase":"","title":"OPAL: \"Opiates and PhArmacoLogy\"","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2013-07-11","conditions":"Substance Use Disorder","enrollment":263},{"nctId":"NCT03483818","phase":"NA","title":"Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy","status":"COMPLETED","sponsor":"NHS Tayside","startDate":"2015-11","conditions":"Hepatitis C","enrollment":152},{"nctId":"NCT01610245","phase":"PHASE3","title":"Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza","status":"COMPLETED","sponsor":"Romark Laboratories L.C.","startDate":"2013-03","conditions":"Influenza","enrollment":1941},{"nctId":"NCT02440256","phase":"NA","title":"Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial","status":"COMPLETED","sponsor":"Simon Fraser University","startDate":"2015-09","conditions":"Opioid Use Disorder, HIV","enrollment":49},{"nctId":"NCT02594592","phase":"","title":"Clinical Value of Self-assessment Risk of Osteoporosis in Chinese","status":"COMPLETED","sponsor":"Hongmei Zhang","startDate":"2015-01","conditions":"Osteoporosis","enrollment":389},{"nctId":"NCT01286714","phase":"NA","title":"Assessment of Fistula Closure by OTSC Clip After Bariatric Surgery","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2011-01","conditions":"Bariatric Surgery (Sleeve Gastrectomy )","enrollment":15},{"nctId":"NCT00509951","phase":"NA","title":"Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2007-07","conditions":"Anxiety Disorders, Specific Phobia","enrollment":154},{"nctId":"NCT00381407","phase":"NA","title":"Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2006-09","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":157}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2450,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"OST","genericName":"OST","companyName":"Pharmbio Korea Co., Ltd.","companyId":"pharmbio-korea-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OST is an osteoclast inhibitor. Used for Treatment of osteoporosis in postmenopausal women and men, Treatment of glucocorticoid-induced osteoporosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}